Laropiprant |
|
| Synonyms: (R)-2-(4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid | |
| Cat. No.: L13600 | CAS No.: 571170-77-9 |
| MDL.: | Formula: C21H19ClFNO4S |
| F.W.435.9 | Purity: 99% |
| Storage: | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | L13600 | CAS No.: | 571170-77-9 | |
| MDL: | Formula: | C21H19ClFNO4S | ||
| F.W.: | 435.9 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Reference: | J. Med. Chem. 2007, 50, 794-806 | |||
| Application: | Laropiprant was a drug used in combination with niacin to reduce blood cholesterol | |||
| Category: | Amines, Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals | |||